Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGM - Nasdaq Real Time Price USD

Keros Therapeutics, Inc. (KROS)

Compare
10.28
+0.24
+(2.39%)
At close: April 3 at 4:00:02 PM EDT
All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-160,869
-160,869
-124,508
-70,062
-62,148
Investing Cash Flow
-1,931
-1,931
-2,464
-1,241
-1,024
Financing Cash Flow
391,821
391,821
178,956
120,309
28,550
End Cash Position
561,380
561,380
332,359
280,375
231,369
Capital Expenditure
-1,931
-1,931
-2,464
-1,241
-1,024
Issuance of Capital Stock
380,134
380,134
175,825
119,578
28,171
Free Cash Flow
-162,800
-162,800
-126,972
-71,303
-63,172
12/31/2021 - 4/8/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HLVX HilleVax, Inc.
1.4500
-3.33%
 
ASMB Assembly Biosciences, Inc.
9.31
-1.69%
 
THRD Third Harmonic Bio, Inc.
3.5700
+0.56%
 
SPRO Spero Therapeutics, Inc.
0.6240
-11.61%
 
GLTO Galecto, Inc.
2.8600
-11.46%
 
RPTX Repare Therapeutics Inc.
1.0500
-1.87%
 
VTYX Ventyx Biosciences, Inc.
1.0000
-5.66%
 
EPIX ESSA Pharma Inc.
1.5800
0.00%
 
KZR Kezar Life Sciences, Inc.
4.5000
-2.17%
 
IPSC Century Therapeutics, Inc.
0.4590
-2.28%